Results 261 to 270 of about 108,435 (311)
Some of the next articles are maybe not open access.
Immunomodulation by Intravenous Immunoglobulin
Journal of Pediatric Hematology/Oncology, 1990In 1980, it was observed in a child with idiopathic thrombocytopenic purpura (ITP) that intravenous administration of pooled human immunoglobulin-G (IVIG) was followed by a rapid increase of the platelet count. Prompted by this finding, a pilot study and two prospective multicenter studies on children with ITP were organized.
P, Imbach +7 more
openaire +2 more sources
INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS
The Lancet, 1983P, Stanley, P, Cole
openaire +4 more sources
Intravenous immunoglobulin consensus statement☆☆☆
Journal of Allergy and Clinical Immunology, 2001Intravenous immunoglobulin (IVIG) preparations are a mainstay for a number of disorders that include primary immuno-deficiency, acute inflammatory conditions, hematological disorders, infections, and neuroimmunological disorders. The range of therapeutic activity is attributed to IVIG's myriad action mechanisms.
openaire +2 more sources
Immunomodulation With Intravenous Immunoglobulin
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993Since its introduction over a decade ago for the treatment of primary immunodeficiencies, intravenous immunoglobulin (IVIG) has demonstrated activity in a variety of autoimmune disorders. An understanding of IVIG's immunomodulatory effects provides the rationale for its potential application in the management of autoimmune disorders.
openaire +2 more sources
Consensus statement. National Institutes of Health Consensus Development Conference, 1991
The National Institutes of Health Consensus Development Conference on Intravenous Immunoglobulin: Prevention and Treatment of Disease brought together biomedical scientists in immunology, infectious disease, and pediatrics, as well as health care providers, patients and their families, and the public to address the safe and effective uses of ...
openaire +1 more source
The National Institutes of Health Consensus Development Conference on Intravenous Immunoglobulin: Prevention and Treatment of Disease brought together biomedical scientists in immunology, infectious disease, and pediatrics, as well as health care providers, patients and their families, and the public to address the safe and effective uses of ...
openaire +1 more source